Filter
853
Text search:
World
Health
Organization
Eastern
Mediterranean
Featured
Recommendations
111
New Publications
178
Language
Document type
No document type
329
Studies & Reports
225
Guidelines
116
Manuals
57
Strategic & Response Plan
48
Fact sheets
23
Situation Updates
18
Training Material
14
Resource Platforms
14
Infographics
5
Brochures
1
App
1
Online Courses
1
Videos
1
Countries / Regions
Global
81
Syria
31
Africa
27
Middle East and North Africa
22
Western and Central Europe
18
Somalia
12
Yemen
11
Pakistan
9
Sudan
9
Latin America and the Carribbean
9
Nigeria
8
South–East Asia Region
8
Eastern Europe
8
Congo, Democratic Republic of
6
Afghanistan
6
Lebanon
6
Sierra Leone
5
Liberia
5
Ethiopia
5
Jordan
5
Kenya
5
Myanmar / Burma
5
West and Central Africa
5
Saudi Arabia
4
Uganda
4
India
4
Nepal
4
Iraq
4
Rwanda
4
East and Southern Africa
4
Asia
4
Ghana
3
Turkey
3
Egypt
3
China
3
Ukraine
3
Russia
3
Iran
3
Senegal
2
South Sudan
2
Cambodia
2
Thailand
2
South Africa
2
Benin
2
Greece
2
Madagascar
2
Eastern Europe and Central Asia
2
Venezuela
2
Albania
2
Djibouti
2
Guinea
1
Morocco
1
USA
1
Cameroon
1
Niger
1
Philippines
1
Tanzania
1
Indonesia
1
Bangladesh
1
Malawi
1
Brazil
1
North Macedonia
1
Serbia
1
Croatia
1
Colombia
1
Ecuador
1
Libya
1
Western Pacific Region
1
Palestine
1
Qatar
1
Georgia
1
Tunisia
1
Authors & Publishers
Publication Years
Category
Countries
123
Clinical Guidelines
119
Public Health
108
Women & Child Health
69
Key Resources
38
Capacity Building
22
Pharmacy & Technologies
18
Toolboxes
Mental Health
107
COVID-19
75
Planetary Health
58
Rapid Response
45
TB
43
NCDs
43
NTDs
38
HIV
37
Global Health Education
35
Conflict
34
AMR
33
Refugee
30
Caregiver
29
Disability
24
Pharmacy
20
Ebola
17
Polio
15
Natural Hazards
12
Cholera
10
Zika
9
Health Financing Toolbox
6
Specific Hazards
4
Typhoon
1
Social Ethics
1
Development of one or more vaccines for Neisseria gonorrhoeae is an important objective for sexual and reproductive health worldwide, and for the fight against antimicrobial resistance.
WHO preferred product characteristics (PPCs) provide strateg
...
The road map sets global targets and milestones to prevent, control, eliminate or eradicate 20 diseases and disease groups as well as cross-cutting targets aligned with the Sustainable Development Goals. Three foundational pillars will support global efforts to achieve the targets: accelerate progra
...
access free courses in more than 60 languages
9 March 2022, Timely and accurate diagnostic testing for SARS-CoV-2 is an essential part of a comprehensive COVID-19 response strategy. Ag-RDTs can be performed by individuals in which they collect their own specimen, perform a simple rapid test and interpret their test result themselves at a time a
...
The report reveals that good IPC programmes can reduce health care infections by 70 %. oday, out of every 100 patients in acute-care hospitals, seven patients in high-income countries and 15 patients in low- and middle-income countries will acquire
...
WHO Technical Series 971
The Committee discussed the implications for preparedness for smallpox-like events reflected by the ongoing COVID-19 pandemic. The Committee noted how quickly diagnostics and vaccines could be developed and deployed when resources and political will were abundant. This rapidity was also due to the f
...
The mhGAP community toolkit: field test version is an integral part of WHO's Mental Health Gap Action Programme (mhGAP), and aims at scaling up services for people with mental health conditions to a
...
Fact Sheet Global Atlas of medical devices
Global tuberculosis report 2022
recommended
The WHO Global Tuberculosis Report 2022 provides a comprehensive and up-to-date assessment of the TB epidemic, and of progress in prevention, diagnosis and treatment of the disease, at global, regional and country levels. This is done in the context of global TB commitments, strategies and targets.
...
Addressing comorbidities and risk factors for TB is a crucial component of Pillar one of the End TB Strategy, which focuses on integrated patient-centred care and prevention, including action on TB and comorbidities. The Framework for collaborative action on TB and comorbidities aims to support coun
...
The Pandemic Influenza Preparedness (PIP) Framework is a World Health Assembly resolution adopted unanimously by all Member States in 2011. It brings together Member States, industry, other stakehol
...
The harmful use of alcohol causes approximately 3 million deaths every year and the overall burden of disease and injuries attributable to alcohol consumption remains unacceptably high. The pace of development and implementation of alcohol policies has been uneven in WHO regions, and resources and c
...
The document explains why vector control is important in national programmes and describes the preparation of a tailor-made vector control plan for national programmes. It outlines entomological procedures for regular and specific vector control and how data should be analysed for better overall und
...
The Strategy to respond to antimalarial drug resistance in Africa is a technical and advocacy document, grounded in the best available evidence to date and aimed at minimizing the threat and impact of antimalarial drug resistance of Plasmodium falciparum parasites in Africa. Its objectives are to: i
...
The COVID-19 pandemic has raised profound ethical challenges on an unprecedented global scale. These challenges include how to allocate scarce resources (especially vaccines and therapeutics), both within and between countries, whether and when to mandate vaccines and/or masks, whether and how to co
...
Globally, more than 3 million new cases and 10 000 deaths have been reported in the week of 26 December 2022 to 1 January 2023. This represents a reduction in weekly cases and deaths of 22% and 12%, respectively. In the last 28 days (5 December 2022 to 1 January 2023), over 14.5 million cases and ov
...
Since 1996, trachoma has been targeted for elimination as a public health problem worldwide. The active trachoma criterion for national elimination as a public health problem is a TF1–9 < 5%, sustained for at least two years in the absence of antibiotic mass drug administration (MDA), in each formerly endemic EU. Using A, F and E,
...
